Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Platelet Rich Plasma (PRP) injections can effectively reduce hair loss and improve hair growth in both men and women suffering from androgenic alopecia.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Higher blood sugar levels may lead to more severe hair loss in women.

Trichoscopy is a helpful and quick method to identify different types of hair loss in women.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Low serum ferritin levels are linked to hair loss in women.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.

Low levels of iron, ferritin, zinc, and folic acid may contribute to hair loss in women.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Women with hair loss should be checked for PCOS, as it's often related and early diagnosis can help with treatment.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

PRP treatment satisfies 58% of female hair loss patients, with most noticing fuller, thicker hair and less shedding.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

PRP injections may improve hair thickness and density in female hair loss patients.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Diffuse hair loss in women is often linked to thyroid problems.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.